BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee JH, Kim SH, Han SH, An JS, Lee ES, Kim YS. Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis. J Gastroenterol Hepatol. 2009;24:354-365. [PMID: 19335785 DOI: 10.1111/j.1440-1746.2009.05775.x] [Cited by in Crossref: 140] [Cited by in F6Publishing: 141] [Article Influence: 10.8] [Reference Citation Analysis]
Number Citing Articles
1 Gonzalez RS, Messing S, Tu X, McMahon LA, Whitney-Miller CL. Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma.Hum Pathol. 2016;56:16-21. [PMID: 27342907 DOI: 10.1016/j.humpath.2016.06.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
2 Iwasaki K, Suda T, Takano Y, Ohno Y, Yamada E, Okazaki N, Takahashi K, Watanabe T, Makuuchi Y, Ota Y, Osaka Y, Seshimo A, Katsumata K, Tsuchida A. Postoperative outcomes of gastric carcinoma with lymphoid stroma. World J Surg Oncol 2020;18:102. [PMID: 32438924 DOI: 10.1186/s12957-020-01878-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Fukayama M, Ushiku T. Epstein-Barr virus-associated gastric carcinoma. Pathol Res Pract. 2011;207:529-537. [PMID: 21944426 DOI: 10.1016/j.prp.2011.07.004] [Cited by in Crossref: 83] [Cited by in F6Publishing: 74] [Article Influence: 7.5] [Reference Citation Analysis]
4 Kimura K, Ebihara Y, Tanaka K, Nakanishi Y, Asano T, Noji T, Kurashima Y, Murakami S, Nakamura T, Tsuchikawa T, Okamura K, Shichinohe T, Kanno-Okada H, Hirano S. Robot-assisted laparoscopic total gastrectomy for Epstein-Barr virus-associated multiple gastric cancer: A case report. Int J Surg Case Rep 2020;75:446-50. [PMID: 33002856 DOI: 10.1016/j.ijscr.2020.09.147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Zhang Y, Chen JN, Dong M, Zhang ZG, Zhang YW, Wu JY, Du H, Li HG, Huang Y, Shao CK. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer. Hum Pathol 2017;63:128-38. [PMID: 28300576 DOI: 10.1016/j.humpath.2017.02.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
6 Moslim MA, Handorf E, Reddy SS, Greco SH, Farma JM. Partial Gastrectomy is Associated with Improved Overall Survival in Signet-Ring Cell Gastric Cancer. J Surg Res 2021;266:27-34. [PMID: 33975027 DOI: 10.1016/j.jss.2021.04.005] [Reference Citation Analysis]
7 Saito M, Nishikawa J, Okada T, Morishige A, Sakai K, Nakamura M, Kiyotoki S, Hamabe K, Okamoto T, Oga A. Role of DNA methylation in the development of Epstein-Barr virus-associated gastric carcinoma. J Med Virol. 2013;85:121-127. [PMID: 23073987 DOI: 10.1002/jmv.23405] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
8 Cui X, Snapper CM. Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases. Front Immunol 2021;12:734471. [PMID: 34691042 DOI: 10.3389/fimmu.2021.734471] [Reference Citation Analysis]
9 Zhao D, Liu S, Sun L, Zhao Z, Liu S, Kuang X, Shu J, Luo B. Glypican-4 gene polymorphism (rs1048369) and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma. Virus Research 2016;220:52-6. [DOI: 10.1016/j.virusres.2016.04.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
10 Zhang YW, Zhao XX, Tan C, Zhang ZG, Jiang Y, Chen JN, Wei HB, Xue L, Li HG, Du H, Shao CK. Epstein-Barr virus latent membrane protein 2A suppresses the expression of HER2 via a pathway involving TWIST and YB-1 in Epstein-Barr virus-associated gastric carcinomas. Oncotarget 2015;6:207-20. [PMID: 25402957 DOI: 10.18632/oncotarget.2702] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
11 Pyo JS, Kim NY, Kang DW. Clinicopathological Significance of EBV-Infected Gastric Carcinomas: A Meta-Analysis. Medicina (Kaunas) 2020;56:E345. [PMID: 32668573 DOI: 10.3390/medicina56070345] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Corvalán AH, Ruedlinger J, de Mayo T, Polakovicova I, Gonzalez-Hormazabal P, Aguayo F. The Phylogeographic Diversity of EBV and Admixed Ancestry in the Americas⁻Another Model of Disrupted Human-Pathogen Co-Evolution. Cancers (Basel) 2019;11:E217. [PMID: 30769835 DOI: 10.3390/cancers11020217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Khoury JD, Tannir NM, Williams MD, Chen Y, Yao H, Zhang J, Thompson EJ, Meric-Bernstam F, Medeiros LJ, Weinstein JN, Su X; TCGA Network. Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq. J Virol 2013;87:8916-26. [PMID: 23740984 DOI: 10.1128/JVI.00340-13] [Cited by in Crossref: 143] [Cited by in F6Publishing: 90] [Article Influence: 15.9] [Reference Citation Analysis]
14 Ribeiro J, Oliveira C, Malta M, Sousa H. Epstein-Barr virus gene expression and latency pattern in gastric carcinomas: a systematic review. Future Oncol 2017;13:567-79. [PMID: 28118740 DOI: 10.2217/fon-2016-0475] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
15 Camargo MC, Anderson WF, King JB, Correa P, Thomas CC, Rosenberg PS, Eheman CR, Rabkin CS. Divergent trends for gastric cancer incidence by anatomical subsite in US adults. Gut 2011;60:1644-9. [PMID: 21613644 DOI: 10.1136/gut.2010.236737] [Cited by in Crossref: 89] [Cited by in F6Publishing: 86] [Article Influence: 8.1] [Reference Citation Analysis]
16 Haas M, Büttner M, Rau TT, Fietkau R, Grabenbauer GG, Distel LV. Inflammation in gastric adenocarcinoma of the cardia: how do EBV infection, Her2 amplification and cancer progression influence tumor-infiltrating lymphocytes? Virchows Arch. 2011;458:403-411. [PMID: 21359545 DOI: 10.1007/s00428-011-1058-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
17 Young LS, Dawson CW. Epstein-Barr virus and nasopharyngeal carcinoma. Chin J Cancer 2014;33:581-90. [PMID: 25418193 DOI: 10.5732/cjc.014.10197] [Cited by in Crossref: 41] [Cited by in F6Publishing: 91] [Article Influence: 5.1] [Reference Citation Analysis]
18 Fang WL, Chen MH, Huang KH, Lin CH, Chao Y, Lo SS, Li AF, Wu CW, Shyr YM. The Clinicopathological Features and Genetic Alterations in Epstein-Barr Virus-Associated Gastric Cancer Patients after Curative Surgery. Cancers (Basel). 2020;12. [PMID: 32531970 DOI: 10.3390/cancers12061517] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
19 Bonelli P, Borrelli A, Tuccillo FM, Silvestro L, Palaia R, Buonaguro FM. Precision medicine in gastric cancer. World J Gastrointest Oncol 2019; 11(10): 804-829 [PMID: 31662821 DOI: 10.4251/wjgo.v11.i10.804] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 34] [Article Influence: 9.7] [Reference Citation Analysis]
20 Luo B, Tang X, Jia Y, Wang Y, Chao Y, Zhao C. Sequence variation of Epstein-Barr virus (EBV) BZLF1 gene in EBV-associated gastric carcinomas and nasopharyngeal carcinomas in Northern China. Microbes and Infection 2011;13:776-82. [DOI: 10.1016/j.micinf.2011.04.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
21 Lee BE. Epstein-Barr Virus-associated Gastric Carcinoma. Korean J Helicobacter Up Gastrointest Res 2021;21:22-8. [DOI: 10.7704/kjhugr.2020.0063] [Reference Citation Analysis]
22 Park JK, Seo JS, Lee SK, Chan KK, Kuh HJ. Combinatorial Antitumor Activity of Oxaliplatin with Epigenetic Modifying Agents, 5-Aza-CdR and FK228, in Human Gastric Cancer Cells. Biomol Ther (Seoul) 2018;26:591-8. [PMID: 30173503 DOI: 10.4062/biomolther.2018.061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
23 Genitsch V, Novotny A, Seiler CA, Kröll D, Walch A, Langer R. Epstein-barr virus in gastro-esophageal adenocarcinomas - single center experiences in the context of current literature. Front Oncol 2015;5:73. [PMID: 25859432 DOI: 10.3389/fonc.2015.00073] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
24 Wu WK, Yu J, Chan MT, To KF, Cheng AS. Combinatorial epigenetic deregulation by Helicobacter pylori and Epstein-Barr virus infections in gastric tumourigenesis. J Pathol 2016;239:245-9. [PMID: 27102722 DOI: 10.1002/path.4731] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
25 Lim H, Park YS, Lee JH, Son DH, Ahn JY, Choi KS, Kim DH, Choi KD, Song HJ, Lee GH, Jung HY, Kim JH, Yook JH, Kim BS. Features of Gastric Carcinoma With Lymphoid Stroma Associated With Epstein-Barr Virus. Clin Gastroenterol Hepatol. 2015;13:1738-1744.e2. [PMID: 25912839 DOI: 10.1016/j.cgh.2015.04.015] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 5.4] [Reference Citation Analysis]
26 Nshizirungu JP, Bennis S, Mellouki I, Sekal M, Benajah DA, Lahmidani N, El Bouhaddouti H, Ibn Majdoub K, Ibrahimi SA, Celeiro SP, Viana-Pereira M, Munari FF, Ribeiro GG, Duval V, Santana I, Reis RM. Reproduction of the Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) Gastric Cancer Molecular Classifications and Their Association with Clinicopathological Characteristics and Overall Survival in Moroccan Patients. Dis Markers 2021;2021:9980410. [PMID: 34367379 DOI: 10.1155/2021/9980410] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Companioni O, Bonet C, Muñoz X, Weiderpass E, Panico S, Tumino R, Palli D, Agnoli C, Vineis P, Boutron-Ruault MC, Racine A, Clavel-Chapelon F, Travis RC, Khaw KT, Riboli E, Murphy N, Vergnaud AC, Trichopoulou A, Benetou V, Trichopoulos D, Lund E, Johansen D, Lindkvist B, Johansson M, Sund M, Ardanaz E, Sánchez-Cantalejo E, Huerta JM, Dorronsoro M, Ramón Quirós J, Tjonneland A, Mortensen LM, Overvad K, Chang-Claude J, Rizzato C, Boeing H, Bueno-de-Mesquita HB, Siersema P, Peeters PH, Numans ME, Carneiro F, Licaj I, Freisling H, Sala N, González CA. Polymorphisms of Helicobacter pylori signaling pathway genes and gastric cancer risk in the European Prospective Investigation into Cancer-Eurgast cohort. Int J Cancer 2014;134:92-101. [PMID: 23824692 DOI: 10.1002/ijc.28357] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
28 Guo C, Wei J, Scott RS, Chen Y, Chen Z, Zhao W, Zhang C, Wang B, Chai C, Dai G, Li M, Zhang F. Prevalence and characteristics of Epstein‐Barr virus associated gastric carcinoma in Gansu Province, Northwest China with mRNA expression of glycoprotein BMRF2. J Med Virol 2020;92:356-63. [DOI: 10.1002/jmv.25616] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
29 Ingerslev K, Høgdall E, Skovrider-Ruminski W, Schnack TH, Lidang M, Høgdall C, Blaakaer J. The prevalence of EBV and CMV DNA in epithelial ovarian cancer. Infect Agent Cancer 2019;14:7. [PMID: 30858874 DOI: 10.1186/s13027-019-0223-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
30 Gulley ML. Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma. Exp Mol Med. 2015;47:e134. [PMID: 25613731 DOI: 10.1038/emm.2014.93] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
31 Mori Y, Akagi K, Yano M, Sashiyama H, Tsutsumi O, Hamahata Y, Tsujinaka Y, Tsuchida A, Matsubayashi J. Lymphoepithelioma-like carcinoma of the colon. Case Rep Gastroenterol. 2013;7:127-133. [PMID: 23626513 DOI: 10.1159/000348765] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
32 Camargo MC, Kim WH, Chiaravalli AM, Kim KM, Corvalan AH, Matsuo K, Yu J, Sung JJ, Herrera-Goepfert R, Meneses-Gonzalez F, Kijima Y, Natsugoe S, Liao LM, Lissowska J, Kim S, Hu N, Gonzalez CA, Yatabe Y, Koriyama C, Hewitt SM, Akiba S, Gulley ML, Taylor PR, Rabkin CS. Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut 2014;63:236-43. [PMID: 23580779 DOI: 10.1136/gutjnl-2013-304531] [Cited by in Crossref: 230] [Cited by in F6Publishing: 210] [Article Influence: 28.8] [Reference Citation Analysis]
33 Chen YP, Zhang WN, Chen L, Tang LL, Mao YP, Li WF, Liu X, Zhou GQ, Sun Y, Kang TB, Zeng MS, Liu N, Ma J. Effect of latent membrane protein 1 expression on overall survival in Epstein-Barr virus-associated cancers: a literature-based meta-analysis. Oncotarget 2015;6:29311-23. [PMID: 26336130 DOI: 10.18632/oncotarget.4906] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
34 Pereira MA, Batista DAM, Ramos MFKP, Cardili L, Ribeiro RRE, Dias AR, Zilberstein B, Ribeiro U Jr, Cecconello I, Alves VAF, Mello ES. Epstein-Barr Virus Positive Gastric Cancer: A Distinct Subtype Candidate for Immunotherapy. J Surg Res 2021;261:130-8. [PMID: 33429221 DOI: 10.1016/j.jss.2020.12.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Tang W, Morgan DR, Meyers MO, Dominguez RL, Martinez E, Kakudo K, Kuan PF, Banet N, Muallem H, Woodward K. Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile. Infect Agent Cancer. 2012;7:21. [PMID: 22929309 DOI: 10.1186/1750-9378-7-21] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
36 Ignatova E, Seriak D, Fedyanin M, Tryakin A, Pokataev I, Menshikova S, Vakhabova Y, Smirnova K, Tjulandin S, Ajani JA. Epstein-Barr virus-associated gastric cancer: disease that requires special approach. Gastric Cancer 2020;23:951-60. [PMID: 32514646 DOI: 10.1007/s10120-020-01095-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
37 Chen JN, He D, Tang F, Shao CK. Epstein-Barr virus-associated gastric carcinoma: a newly defined entity. J Clin Gastroenterol. 2012;46:262-271. [PMID: 22392024 DOI: 10.1097/mcg.0b013e318249c4b8] [Cited by in Crossref: 59] [Cited by in F6Publishing: 27] [Article Influence: 5.9] [Reference Citation Analysis]
38 Gao Y, Fu Y, Wang J, Zheng X, Zhou J, Ma J. EBV as a high infection risk factor promotes RASSF10 methylation and induces cell proliferation in EBV-associated gastric cancer. Biochem Biophys Res Commun 2021;547:1-8. [PMID: 33588233 DOI: 10.1016/j.bbrc.2021.02.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Rajendra K, Sharma P. Viral Pathogens in Oesophageal and Gastric Cancer. Pathogens 2022;11:476. [PMID: 35456151 DOI: 10.3390/pathogens11040476] [Reference Citation Analysis]
40 Zhao J, Liang Q, Cheung KF, Kang W, Lung RW, Tong JH, To KF, Sung JJ, Yu J. Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells. Cancer. 2013;119:304-312. [PMID: 22833454 DOI: 10.1002/cncr.27724] [Cited by in Crossref: 88] [Cited by in F6Publishing: 85] [Article Influence: 8.8] [Reference Citation Analysis]
41 Kim YB, Hur H, Lee D. Frequent EBV positivity in conventional adenocarcinomas occurring simultaneously with EBV-associated gastric cancers. Pathology 2016;48:616-8. [PMID: 27567229 DOI: 10.1016/j.pathol.2016.05.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
42 Merz H, Marnitz S, Erbersdobler A, Goektas O. Schmincke's Tumor, Carcinoma of the Base of the Tongue c T1-2, cN2c M0 - A Case Report. Case Rep Oncol 2010;3:77-82. [PMID: 20740163 DOI: 10.1159/000302139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
43 Aguayo F, Boccardo E, Corvalán A, Calaf GM, Blanco R. Interplay between Epstein-Barr virus infection and environmental xenobiotic exposure in cancer. Infect Agent Cancer 2021;16:50. [PMID: 34193233 DOI: 10.1186/s13027-021-00391-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Young LS, Yap LF, Murray PG. Epstein-Barr virus: more than 50 years old and still providing surprises. Nat Rev Cancer. 2016;16:789-802. [PMID: 27687982 DOI: 10.1038/nrc.2016.92] [Cited by in Crossref: 296] [Cited by in F6Publishing: 287] [Article Influence: 49.3] [Reference Citation Analysis]
45 Zhai X, Liu J, Lu D, Zhou Q. Demographics, clinical features, and prognosis of rare lymphoepithelioma-like carcinoma across different anatomic sites. J Egypt Natl Canc Inst 2022;34. [DOI: 10.1186/s43046-021-00103-2] [Reference Citation Analysis]
46 Park JH, Kim EK, Kim YH, Kim JH, Bae YS, Lee YC, Cheong JH, Noh SH, Kim H. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer. Gastric Cancer. 2016;19:1041-1051. [PMID: 26573601 DOI: 10.1007/s10120-015-0565-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
47 Lunardi F, Calabrese F, Furian L, Rigotti P, Valente M. Epstein-Barr virus-associated gastric carcinoma 33 years after kidney transplantation. NDT Plus 2011;4:49-52. [PMID: 25984103 DOI: 10.1093/ndtplus/sfq197] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Camargo MC, Murphy G, Koriyama C, Pfeiffer RM, Kim WH, Herrera-Goepfert R, Corvalan AH, Carrascal E, Abdirad A, Anwar M, Hao Z, Kattoor J, Yoshiwara-Wakabayashi E, Eizuru Y, Rabkin CS, Akiba S. Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis. Br J Cancer 2011;105:38-43. [PMID: 21654677 DOI: 10.1038/bjc.2011.215] [Cited by in Crossref: 96] [Cited by in F6Publishing: 91] [Article Influence: 8.7] [Reference Citation Analysis]
49 Son BK, Kim DH, Min KW, Kim EK, Kwon MJ. Smad4/Fascin index is highly prognostic in patients with diffuse type EBV-associated gastric cancer. Pathol Res Pract 2018;214:475-81. [PMID: 29572117 DOI: 10.1016/j.prp.2018.03.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
50 Shen H, Zhong M, Wang W, Liao P, Yin X, Rotroff D, Knepper TC, Mcleod HL, Zhou C, Xie S, Li W, Xu B, He Y. EBV infection and MSI status significantly influence the clinical outcomes of gastric cancer patients. Clin Chim Acta 2017;471:216-21. [PMID: 28601671 DOI: 10.1016/j.cca.2017.06.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
51 Tavakoli A, Monavari SH, Solaymani Mohammadi F, Kiani SJ, Armat S, Farahmand M. Association between Epstein-Barr virus infection and gastric cancer: a systematic review and meta-analysis. BMC Cancer 2020;20:493. [PMID: 32487043 DOI: 10.1186/s12885-020-07013-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
52 Elgui de Oliveira D, Müller-Coan BG, Pagano JS. Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers. Trends Microbiol. 2016;24:649-664. [PMID: 27068530 DOI: 10.1016/j.tim.2016.03.008] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 9.3] [Reference Citation Analysis]
53 Suzuki Y, Inoshita N, Kikuchi D, Nomura K, Matsui A, Hoteya S. Clinicopathological features of Epstein-Barr virus-associated superficial early stage gastric cancer treated with endoscopic submucosal dissection. Dig Liver Dis 2021:S1590-8658(21)00764-7. [PMID: 34535407 DOI: 10.1016/j.dld.2021.08.023] [Reference Citation Analysis]
54 Nishikawa J, Yoshiyama H, Iizasa H, Kanehiro Y, Nakamura M, Nishimura J, Saito M, Okamoto T, Sakai K, Suehiro Y. Epstein-barr virus in gastric carcinoma. Cancers (Basel). 2014;6:2259-2274. [PMID: 25386788 DOI: 10.3390/cancers6042259] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 5.5] [Reference Citation Analysis]
55 Kim HJ, Hwang SW, Kim N, Yoon H, Shin CM, Park YS, Lee DH, Park DJ, Kim HH, Kim JS, Jung HC, Lee HS. Helicobacter pylori and Molecular Markers as Prognostic Indicators for Gastric Cancer in Korea. J Cancer Prev 2014;19:56-67. [PMID: 25337573 DOI: 10.15430/jcp.2014.19.1.56] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
56 Wang Y, Zhang X, Chao Y, Jia Y, Xing X, Luo B. New variations of Epstein-Barr virus-encoded small RNA genes in nasopharyngeal carcinomas, gastric carcinomas, and healthy donors in northern China. J Med Virol. 2010;82:829-836. [PMID: 20336720 DOI: 10.1002/jmv.21714] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
57 Iizasa H, Nanbo A, Nishikawa J, Jinushi M, Yoshiyama H. Epstein-Barr Virus (EBV)-associated gastric carcinoma. Viruses. 2012;4:3420-3439. [PMID: 23342366 DOI: 10.3390/v4123420] [Cited by in Crossref: 127] [Cited by in F6Publishing: 114] [Article Influence: 14.1] [Reference Citation Analysis]
58 Wang ZH, Zhao JJ, Yuan Z. Lymphoepithelioma-like gastric carcinoma: A case report and review of the literature. World J Gastroenterol 2016; 22(10): 3056-3061 [PMID: 26973402 DOI: 10.3748/wjg.v22.i10.3056] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
59 Kang W, To KF. Are Epstein-Barr Virus-positive and -negative Gastric Carcinomas, With Lymphoid Stroma, Single Entity or Different Entities? Clin Gastroenterol Hepatol 2015;13:1745-7. [PMID: 26122759 DOI: 10.1016/j.cgh.2015.06.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
60 Fierti AO, Yakass MB, Okertchiri EA, Adadey SM, Quaye O. The Role of Epstein-Barr Virus in Modulating Key Tumor Suppressor Genes in Associated Malignancies: Epigenetics, Transcriptional, and Post-Translational Modifications. Biomolecules 2022;12:127. [DOI: 10.3390/biom12010127] [Reference Citation Analysis]
61 Chang MS, Kim DH, Roh JK, Middeldorp JM, Kim YS, Kim S, Han S, Kim CW, Lee BL, Kim WH, Woo JH. Epstein-Barr virus-encoded BARF1 promotes proliferation of gastric carcinoma cells through regulation of NF-κB. J Virol 2013;87:10515-23. [PMID: 23824821 DOI: 10.1128/JVI.00955-13] [Cited by in Crossref: 47] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
62 Kaźmierczak-Siedlecka K, Daca A, Roviello G, Catalano M, Połom K. Interdisciplinary insights into the link between gut microbiome and gastric carcinogenesis-what is currently known? Gastric Cancer 2021. [PMID: 34741681 DOI: 10.1007/s10120-021-01260-y] [Reference Citation Analysis]
63 Chen XZ, Chen H, Castro FA, Hu JK, Brenner H. Epstein-Barr virus infection and gastric cancer: a systematic review. Medicine (Baltimore) 2015;94:e792. [PMID: 25997049 DOI: 10.1097/MD.0000000000000792] [Cited by in Crossref: 65] [Cited by in F6Publishing: 42] [Article Influence: 9.3] [Reference Citation Analysis]
64 Ramos MFKP, Pereira MA, Dias AR, Faraj SF, Zilberstein B, Cecconello I, de Mello ES, Ribeiro Junior U. Lymphoepithelioma-like gastric carcinoma: clinicopathological characteristics and infection status. J Surg Res 2017;210:159-68. [PMID: 28457323 DOI: 10.1016/j.jss.2016.11.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
65 Angerilli V, Galuppini F, Pennelli G, Fanelli GN, d'Amore ESG, Michelotto M, Pilati P, Spolverato G, Pucciarelli S, Scarpa M, Farinati F, Savarino E, Realdon S, Lonardi S, Bergamo F, Loupakis F, Dei Tos AP, Vanoli A, Fassan M. Epstein-Barr virus associated gastric dysplasia: a new rare entity? Virchows Arch 2021. [PMID: 34537878 DOI: 10.1007/s00428-021-03206-2] [Reference Citation Analysis]
66 Jain N, Goyal S, Sakhuja P, Saluja S. Epstein-Barr Virus-associated Mixed Lymphoepithelioma-like Carcinoma and Adenocarcinoma of the Gall Bladder: An Unusual Entity. Korean J Gastroenterol 2021;78:188-94. [PMID: 34565789 DOI: 10.4166/kjg.2021.045] [Reference Citation Analysis]
67 Cho J, Kang MS, Kim KM. Epstein-Barr Virus-Associated Gastric Carcinoma and Specific Features of the Accompanying Immune Response. J Gastric Cancer. 2016;16:1-7. [PMID: 27104020 DOI: 10.5230/jgc.2016.16.1.1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
68 Song HJ, Kim KM. Pathology of epstein-barr virus-associated gastric carcinoma and its relationship to prognosis. Gut Liver. 2011;5:143-148. [PMID: 21814592 DOI: 10.5009/gnl.2011.5.2.143] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
69 Iyer P, Moslim M, Farma JM, Denlinger CS. Diffuse gastric cancer: histologic, molecular, and genetic basis of disease. Transl Gastroenterol Hepatol 2020;5:52. [PMID: 33073047 DOI: 10.21037/tgh.2020.01.02] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
70 Lee SH, Choi SJ, Choi W, Cho S, Cho M, Kim DS, Kang BW, Kim JG, Lee YM, Cho H, Kang H. Cisplatin Resistance in Epstein-Barr-Virus-Associated Gastric Carcinoma Acquired through ATM Methylation. Cancers (Basel) 2021;13:4252. [PMID: 34503060 DOI: 10.3390/cancers13174252] [Reference Citation Analysis]
71 Yang K, Lu L, Liu H, Wang X, Gao Y, Yang L, Li Y, Su M, Jin M, Khan S. A comprehensive update on early gastric cancer: defining terms, etiology, and alarming risk factors. Expert Rev Gastroenterol Hepatol 2021;15:255-73. [PMID: 33121300 DOI: 10.1080/17474124.2021.1845140] [Reference Citation Analysis]
72 Hori T, Yamamoto H, Harada H, Yamamoto M, Yamada M, Yazawa T, Sasaki B, Tani M, Sato A, Katsura H, Kamada Y, Tani R, Aoyama R, Sasaki Y, Shintaku M, Iwasa Y, Zaima M. Multiple Gastric Carcinomas Associated with Epstein-Barr Virus and Helicobacter pylori: A Thought-Provoking Case. Am J Case Rep 2021;22:e931668. [PMID: 34158469 DOI: 10.12659/AJCR.931668] [Reference Citation Analysis]
73 Costa NR, Gil da Costa RM, Medeiros R. A viral map of gastrointestinal cancers. Life Sci 2018;199:188-200. [PMID: 29476768 DOI: 10.1016/j.lfs.2018.02.025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
74 Li X, Sun ZQ, Jiang XL. Advances in research of Epstein-Barr virus-associated gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2011; 19(32): 3323-3326 [DOI: 10.11569/wcjd.v19.i32.3323] [Reference Citation Analysis]
75 Han J, Chen JN, Zhang ZG, Li HG, Ding YG, Du H, Shao CK. Sequence variations of latent membrane protein 2A in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China. PLoS One 2012;7:e34276. [PMID: 22470549 DOI: 10.1371/journal.pone.0034276] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
76 Gasenko E, Isajevs S, Camargo MC, Offerhaus GJA, Polaka I, Gulley ML, Skapars R, Sivins A, Kojalo I, Kirsners A, Santare D, Pavlova J, Sjomina O, Liepina E, Tzivian L, Rabkin CS, Leja M. Clinicopathological characteristics of Epstein-Barr virus-positive gastric cancer in Latvia. Eur J Gastroenterol Hepatol 2019;31:1328-33. [PMID: 31569122 DOI: 10.1097/MEG.0000000000001521] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
77 Naseem M, Barzi A, Brezden-Masley C, Puccini A, Berger MD, Tokunaga R, Battaglin F, Soni S, McSkane M, Zhang W, Lenz HJ. Outlooks on Epstein-Barr virus associated gastric cancer. Cancer Treat Rev 2018;66:15-22. [PMID: 29631196 DOI: 10.1016/j.ctrv.2018.03.006] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 12.5] [Reference Citation Analysis]
78 Chen JN, Zhang NN, Jiang Y, Hui DY, Wen ZJ, Li HG, Ding YG, Du H, Shao CK. Variations of Epstein-Barr virus nuclear antigen 1 in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China. PLoS One 2012;7:e50084. [PMID: 23189182 DOI: 10.1371/journal.pone.0050084] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
79 Khan G, Hassani A. Presence of Epstein-Barr virus in gastric adenocarcinoma in Indian patients. Indian J Med Microbiol 2016;34:407-8. [PMID: 27514983 DOI: 10.4103/0255-0857.176850] [Reference Citation Analysis]
80 Choi MG, Jeong JY, Kim KM, Bae JM, Noh JH, Sohn TS, Kim S. Clinical significance of gastritis cystica profunda and its association with Epstein-Barr virus in gastric cancer. Cancer. 2012;118:5227-5233. [PMID: 22511405 DOI: 10.1002/cncr.27541] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
81 Danilova NV, Malkov PG, Oleynikova NA, Mikhailov IA. [Epstein-Barr virus-associated gastric adenocarcinoma]. Arkh Patol 2019;81:74-83. [PMID: 31317934 DOI: 10.17116/patol20198103174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
82 Guo H, Wang T, Su HX. Epstein-Barr virus and gastric cancer. Shijie Huaren Xiaohua Zazhi 2013; 21(17): 1616-1622 [DOI: 10.11569/wcjd.v21.i17.1616] [Reference Citation Analysis]
83 Han S, Tay JK, Loh CJL, Chu AJM, Yeong JPS, Lim CM, Toh HC. Epstein–Barr Virus Epithelial Cancers—A Comprehensive Understanding to Drive Novel Therapies. Front Immunol 2021;12:734293. [DOI: 10.3389/fimmu.2021.734293] [Reference Citation Analysis]
84 Carrasco-Avino G, Riquelme I, Padilla O, Villaseca M, Aguayo FR, Corvalan AH. The conundrum of the Epstein-Barr virus-associated gastric carcinoma in the Americas. Oncotarget 2017;8:75687-98. [PMID: 29088902 DOI: 10.18632/oncotarget.18497] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
85 Zeng ZM, Luo FF, Zou LX, He RQ, Pan DH, Chen X, Xie TT, Li YQ, Peng ZG, Chen G. Human papillomavirus as a potential risk factor for gastric cancer: a meta-analysis of 1,917 cases. Onco Targets Ther. 2016;9:7105-7114. [PMID: 27895502 DOI: 10.2147/ott.s115053] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
86 Ribeiro J, Malta M, Galaghar A, Silva F, Afonso LP, Medeiros R, Sousa H. P53 deregulation in Epstein-Barr virus-associated gastric cancer. Cancer Lett 2017;404:37-43. [PMID: 28729047 DOI: 10.1016/j.canlet.2017.07.010] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
87 Lu C, Zhang H, Zhou W, Wan X, Li L, Yu C. Epstein-Barr virus infection and genome polymorphisms on gastric remnant carcinoma: a meta-analysis. Cancer Cell Int. 2020;20:401. [PMID: 32843851 DOI: 10.1186/s12935-020-01498-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Kim SW, Shin HC, Kim IY, Kim CJ, Lee JH, Lee CK, Jeong DJ. Epstein-Barr virus-associated lymphoepithelioma-like gastric carcinoma presenting as a submucosal mass: CT findings with pathologic correlation. Korean J Radiol. 2010;11:697-700. [PMID: 21076598 DOI: 10.3348/kjr.2010.11.6.697] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
89 Ognjenovic L, Shumkovski A, Gjoshev S, Volchevski G, Trajkovski G, Karadzov Z, Dzambaz D, Hadzi-Manchev D, Hadzi-Manchev T, Petrushevska G, Janevska V, Janevski V, Brzanov N. EBV Positive Gastric Carcinomas and Their Clinicopathological Characteristics. Open Access Maced J Med Sci 2018;6:1829-32. [PMID: 30455757 DOI: 10.3889/oamjms.2018.409] [Reference Citation Analysis]
90 Qiu MZ, He CY, Lu SX, Guan WL, Wang F, Wang XJ, Jin Y, Wang FH, Li YH, Shao JY, Zhou ZW, Yun JP, Xu RH. Prospective observation: Clinical utility of plasma Epstein-Barr virus DNA load in EBV-associated gastric carcinoma patients. Int J Cancer 2020;146:272-80. [PMID: 31162842 DOI: 10.1002/ijc.32490] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
91 Fattahi S, Nikbakhsh N, Taheri H, Ghadami E, Kosari-monfared M, Amirbozorgi G, Asouri M, Pilehchian-langroudi M, Ranaee M, Samadani AA, Paryan M, Akhavan-niaki H. Prevalence of multiple infections and the risk of gastric adenocarcinoma development at earlier age. Diagnostic Microbiology and Infectious Disease 2018;92:62-8. [DOI: 10.1016/j.diagmicrobio.2018.04.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
92 Song L, Song M, Camargo MC, Van Duine J, Williams S, Chung Y, Kim KM, Lissowska J, Sivins A, Gao W, Karthikeyan K, Park J, Leja M, Cohen JI, LaBaer J, Qiu J, Rabkin CS. Identification of anti-Epstein-Barr virus (EBV) antibody signature in EBV-associated gastric carcinoma. Gastric Cancer 2021;24:858-67. [PMID: 33661412 DOI: 10.1007/s10120-021-01170-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
93 Chen JN, Jiang Y, Li HG, Ding YG, Fan XJ, Xiao L, Han J, Du H, Shao CK. Epstein-Barr virus genome polymorphisms of Epstein-Barr virus-associated gastric carcinoma in gastric remnant carcinoma in Guangzhou, southern China, an endemic area of nasopharyngeal carcinoma. Virus Res 2011;160:191-9. [PMID: 21723347 DOI: 10.1016/j.virusres.2011.06.011] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
94 Smith C, Khanna R. Adoptive therapy for EBV-induced cancers: driving success with post-transplant lymphoproliferative disorder to other EBV-derived tumors. Immunotherapy 2015;7:563-72. [DOI: 10.2217/imt.15.7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
95 Ribeiro J, Oliveira A, Malta M, Oliveira C, Silva F, Galaghar A, Afonso LP, Neves MC, Medeiros R, Pimentel-Nunes P, Sousa H. Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal. World J Gastroenterol 2017; 23(40): 7292-7302 [PMID: 29142476 DOI: 10.3748/wjg.v23.i40.7292] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
96 Shannon-Lowe C, Rickinson A. The Global Landscape of EBV-Associated Tumors. Front Oncol 2019;9:713. [PMID: 31448229 DOI: 10.3389/fonc.2019.00713] [Cited by in Crossref: 101] [Cited by in F6Publishing: 99] [Article Influence: 33.7] [Reference Citation Analysis]
97 Kim GH. Endoscopic Submucosal Dissection for Early Gastric Cancers with Uncommon Histology. Clin Endosc 2016;49:434-7. [PMID: 27744663 DOI: 10.5946/ce.2016.127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
98 Danilova NV, Mikhailov IA, Kalinin DV, Oleynikova NA, Chayka AV, Khomyakov VM, Kakotkin VV, Yudin MY, Vychuzhanin DV, Andreeva YY, Malkov PG. [Study of gastric adenocarcinomas association with the Epstein-Barr virus-encoded small RNAs]. Arkh Patol 2022;84:5-12. [PMID: 35417943 DOI: 10.17116/patol2022840215] [Reference Citation Analysis]
99 Cui X, Cao Z, Ishikawa Y, Cui S, Imadome KI, Snapper CM. Immunization with Epstein-Barr Virus Core Fusion Machinery Envelope Proteins Elicit High Titers of Neutralizing Activities and Protect Humanized Mice from Lethal Dose EBV Challenge. Vaccines (Basel) 2021;9:285. [PMID: 33808755 DOI: 10.3390/vaccines9030285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
100 Khan G, Hashim MJ. Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010. Infect Agent Cancer. 2014;9:38. [PMID: 25473414 DOI: 10.1186/1750-9378-9-38] [Cited by in Crossref: 95] [Cited by in F6Publishing: 95] [Article Influence: 11.9] [Reference Citation Analysis]
101 Pagano JS, Blaser M, Buendia MA, Damania B, Khalili K, Raab-Traub N, Roizman B. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol. 2004;14:453-471. [PMID: 15489139 DOI: 10.1016/j.semcancer.2014.04.004] [Cited by in Crossref: 103] [Cited by in F6Publishing: 90] [Article Influence: 6.1] [Reference Citation Analysis]
102 Wang X, Wang Y, Wu G, Chao Y, Sun Z, Luo B. Sequence analysis of Epstein-Barr virus EBNA-2 gene coding amino acid 148-487 in nasopharyngeal and gastric carcinomas. Virol J 2012;9:49. [PMID: 22348267 DOI: 10.1186/1743-422X-9-49] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
103 朱晓芸, 李夏, 李素琴, 于红刚. EBV相关性胃癌研究进展. 世界华人消化杂志 2017; 25(15): 1375-1381 [DOI: 10.11569/wcjd.v25.i15.1375] [Reference Citation Analysis]
104 Liu X, Tang X, Zhang S, Wang Y, Wang X, Zhao C, Luo B. Methylation and Expression of Retinoblastoma and Transforming Growth Factor-β1 Genes in Epstein-Barr Virus-Associated and -Negative Gastric Carcinomas. Gastroenterol Res Pract 2012;2012:906017. [PMID: 23008701 DOI: 10.1155/2012/906017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
105 Wang J, Zheng X, Qin Z, Wei L, Lu Y, Peng Q, Gao Y, Zhang X, Zhang X, Li Z, Fu Y, Liu P, Liu C, Yan Q, Xiong W, Li G, Lu J, Ma J. Epstein-Barr virus miR-BART3-3p promotes tumorigenesis by regulating the senescence pathway in gastric cancer. J Biol Chem 2019;294:4854-66. [PMID: 30674552 DOI: 10.1074/jbc.RA118.006853] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
106 Han WH, Eom BW, Yoon HM, Kim YW, Kook MC, Ryu KW. The Different Clinicopathological Features of Remnant Gastric Cancer Depending on Initial Disease of Partial Gastrectomy. Cancers (Basel) 2020;12:E2847. [PMID: 33023082 DOI: 10.3390/cancers12102847] [Reference Citation Analysis]
107 Nie Y, Sun Y, Wang Y, Liu C, Zhao C, Luo B. Epstein-Barr virus gene polymorphism in different parts of the same nasopharyngeal carcinoma patient. Arch Virol 2013;158:1031-7. [DOI: 10.1007/s00705-012-1578-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
108 Kang HJ, Lee I, Park Y, Ho WJ, Sohn D, Ahn J, Yook J, Kim B. Biomarkers of EBV-positive Gastric Cancers: Loss of PTEN Expression is Associated with Poor Prognosis and Nodal Metastasis. Ann Surg Oncol 2016;23:3684-92. [DOI: 10.1245/s10434-016-5284-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
109 Bang CS, Baik GH. Pitfalls in the Interpretation of Publications about Endoscopic Submucosal Dissection of Early Gastric Cancer with Undifferentiated-Type Histology. Clin Endosc 2019;52:30-5. [PMID: 30650945 DOI: 10.5946/ce.2018.158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
110 Min BH, Tae CH, Ahn SM, Kang SY, Woo SY, Kim S, Kim KM. Epstein-Barr virus infection serves as an independent predictor of survival in patients with lymphoepithelioma-like gastric carcinoma. Gastric Cancer 2016;19:852-9. [PMID: 26265391 DOI: 10.1007/s10120-015-0524-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
111 Zhang C, Wen HL, Zhang R, Xie SY, Xie CM. Computed tomography radiomics to predict EBER positivity in Epstein-Barr virus-associated gastric adenocarcinomas: a retrospective study. Acta Radiol 2021;:2841851211029083. [PMID: 34233501 DOI: 10.1177/02841851211029083] [Reference Citation Analysis]
112 Salyakina D, Tsinoremas NF. Viral expression associated with gastrointestinal adenocarcinomas in TCGA high-throughout sequencing data. Hum Genomics. 2013;23. [PMID: 24279398 DOI: 10.1186/1479-7364-7-23] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
113 Tang F, Chen JN, Zhang NN, Gong LP, Jiang Y, Feng ZY, Xiao L, Li HG, Du H, Wu B, Shao CK. Expression of CCL21 by EBV-associated gastric carcinoma cells protects CD8+CCR7+ T lymphocytes from apoptosis via the mitochondria-mediated pathway. Pathology 2018;50:613-21. [PMID: 30149990 DOI: 10.1016/j.pathol.2018.05.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
114 Re V, Brisotto G, Repetto O, De Zorzi M, Caggiari L, Zanussi S, Alessandrini L, Canzonieri V, Miolo G, Puglisi F, Belluco C, Steffan A, Cannizzaro R. Overview of Epstein-Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options. Int J Mol Sci 2020;21:E9400. [PMID: 33321820 DOI: 10.3390/ijms21249400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
115 Wang R, Liu K, Chen XZ; SIGES research group. Associations between gastric cancer risk and virus infection other than Epstein-Barr virus: The protocol of a systematic review and meta-analysis based on epidemiological studies. Medicine (Baltimore) 2019;98:e16708. [PMID: 31393376 DOI: 10.1097/MD.0000000000016708] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
116 Wei J, Guo C, An X, Miao W, Zhang C, Wang B, Cai W, Li M, Zhang F. Tumor cell-expressed IL-15Rα drives antagonistic effects on the progression and immune control of gastric cancer and is epigenetically regulated in EBV-positive gastric cancer. Cell Oncol (Dordr) 2020;43:1085-97. [PMID: 32767257 DOI: 10.1007/s13402-020-00542-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
117 Zheng X, Huang Y, Li K, Luo R, Cai M, Yun J. Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein–Barr Virus-Associated Malignancies. Viruses 2022;14:1017. [DOI: 10.3390/v14051017] [Reference Citation Analysis]
118 Kim S, Hur DY, Hong S, Kim JH. EBV-encoded EBNA1 regulates cell viability by modulating miR34a-NOX2-ROS signaling in gastric cancer cells. Biochemical and Biophysical Research Communications 2017;494:550-5. [DOI: 10.1016/j.bbrc.2017.10.095] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
119 Moslim MA, Deng M, Handorf E, Greco SH, Farma JM. Optimal care and survival for signet-ring cell and non-signet-ring cell gastric cancer are more achievable at academic cancer centers. Am J Surg 2021:S0002-9610(21)00287-7. [PMID: 34045068 DOI: 10.1016/j.amjsurg.2021.05.007] [Reference Citation Analysis]
120 Khan G, Fitzmaurice C, Naghavi M, Ahmed LA. Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable malignancies, 1990-2017. BMJ Open 2020;10:e037505. [PMID: 32868361 DOI: 10.1136/bmjopen-2020-037505] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
121 Wang Y, Liu X, Xing X, Cui Y, Zhao C, Luo B. Variations of Epstein-Barr virus nuclear antigen 1 gene in gastric carcinomas and nasopharyngeal carcinomas from Northern China. Virus Res 2010;147:258-64. [PMID: 19941915 DOI: 10.1016/j.virusres.2009.11.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
122 Bai Y, Xie T, Wang Z, Tong S, Zhao X, Zhao F, Cai J, Wei X, Peng Z, Shen L. Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer. J Immunother Cancer 2022;10:e004080. [PMID: 35241494 DOI: 10.1136/jitc-2021-004080] [Reference Citation Analysis]
123 Liu S, Zhao Z, Han L, Liu S, Luo B. Epstein-Barr Virus Infection in Gastric Remnant Carcinoma and Recurrent Gastric Carcinoma in Qingdao of Northern China. PLoS One 2016;11:e0148342. [PMID: 26859565 DOI: 10.1371/journal.pone.0148342] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
124 Ryan JL, Jones RJ, Kenney SC, Rivenbark AG, Tang W, Knight ER, Coleman WB, Gulley ML. Epstein-Barr virus-specific methylation of human genes in gastric cancer cells. Infect Agent Cancer 2010;5:27. [PMID: 21194482 DOI: 10.1186/1750-9378-5-27] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
125 Park S, Choi MG, Kim KM, Kim HS, Jung SH, Lee JH, Noh JH, Sohn TS, Bae JM, Kim S. Lymphoepithelioma-like carcinoma: a distinct type of gastric cancer. J Surg Res 2015;194:458-63. [PMID: 25592274 DOI: 10.1016/j.jss.2014.12.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
126 Lung RW, Tong JH, To KF. Emerging roles of small Epstein-Barr virus derived non-coding RNAs in epithelial malignancy. Int J Mol Sci. 2013;14:17378-17409. [PMID: 23979421 DOI: 10.3390/ijms140917378] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
127 Speck O, Tang W, Morgan DR, Kuan PF, Meyers MO, Dominguez RL, Martinez E, Gulley ML. Three Molecular Subtypes of Gastric Adenocarcinoma Have Distinct Histochemical Features Reflecting Epstein-Barr Virus Infection Status and Neuroendocrine Differentiation. Appl Immunohistochem Mol Morphol 2015;23:633-45. [PMID: 25517873 DOI: 10.1097/PAI.0000000000000122] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
128 Parkin DM, Hämmerl L, Ferlay J, Kantelhardt EJ. Cancer in Africa 2018: The role of infections. Int J Cancer 2020;146:2089-103. [PMID: 31254479 DOI: 10.1002/ijc.32538] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
129 Zhang YW, He D, Tan C, Dong M, Zhou L, Shao CK. Differential expression of HER2 and downstream proteins in prediction of advanced tumor phenotypes and overall survival of patients with Epstein-Barr virus-positive vs. negative gastric cancers. Pathol Res Pract 2019;215:152675. [PMID: 31594682 DOI: 10.1016/j.prp.2019.152675] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
130 Jing JJ, Li H, Wang ZY, Zhou H, Sun LP, Yuan Y. Aberrantly methylated-differentially expressed genes and pathways in Epstein-Barr virus-associated gastric cancer. Future Oncol 2020;16:187-97. [PMID: 31989840 DOI: 10.2217/fon-2019-0649] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
131 Kim SY, Park C, Kim HJ, Park J, Hwang J, Kim JI, Choi MG, Kim S, Kim KM, Kang MS. Deregulation of immune response genes in patients with Epstein-Barr virus-associated gastric cancer and outcomes. Gastroenterology. 2015;148:137-147.e9. [PMID: 25254613 DOI: 10.1053/j.gastro.2014.09.020] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 8.3] [Reference Citation Analysis]
132 Bae JM, Kim EH. Epstein-Barr Virus and Gastric Cancer Risk: A Meta-analysis With Meta-regression of Case-control Studies. J Prev Med Public Health. 2016;49:97-107. [PMID: 27055546 DOI: 10.3961/jpmph.15.068] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 5.7] [Reference Citation Analysis]
133 Figueiredo C, Camargo MC, Leite M, Fuentes-Pananá EM, Rabkin CS, Machado JC. Pathogenesis of Gastric Cancer: Genetics and Molecular Classification. Curr Top Microbiol Immunol 2017;400:277-304. [PMID: 28124158 DOI: 10.1007/978-3-319-50520-6_12] [Cited by in Crossref: 19] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
134 Kim JW, Kim JH, Kim HM. Incidence and survival rates of lymphoepithelioma-like gastric carcinoma: analysis of the Korea Central Cancer Registry Database. Scand J Gastroenterol 2021;:1-5. [PMID: 34338128 DOI: 10.1080/00365521.2021.1955966] [Reference Citation Analysis]
135 Xu Q, DU J, Liu B. Lymphoepithelioma-like gastric carcinoma located in the lesser curvature of the gastric body: A case report and review of the literature. Mol Clin Oncol 2016;4:405-8. [PMID: 26998292 DOI: 10.3892/mco.2015.717] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
136 Cárdenas-Mondragón MG, Torres J, Flores-Luna L, Camorlinga-Ponce M, Carreón-Talavera R, Gomez-Delgado A, Kasamatsu E, Fuentes-Pananá EM. Case–control study of Epstein–Barr virus and Helicobacter pylori serology in Latin American patients with gastric disease. Br J Cancer 2015;112:1866-73. [PMID: 25996206 DOI: 10.1038/bjc.2015.175] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
137 Ribeiro J, Malta M, Galaghar A, Afonso LP, Libânio D, Medeiros R, Dinis-Ribeiro M, Pimentel-Nunes P, Sousa H. Epstein-Barr virus is absent in gastric superficial neoplastic lesions. Virchows Arch 2019;475:757-62. [PMID: 31673776 DOI: 10.1007/s00428-019-02670-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
138 Osumi H, Kawachi H, Yoshio T, Fujisaki J. Clinical impact of Epstein‐Barr virus status on the incidence of lymph node metastasis in early gastric cancer. Digestive Endoscopy 2020;32:316-22. [DOI: 10.1111/den.13584] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
139 Li S, Du H, Wang Z, Zhou L, Zhao X, Zeng Y. Meta-analysis of the relationship between Epstein-Barr virus infection and clinicopathological features of patients with gastric carcinoma. Sci China Life Sci 2010;53:524-30. [PMID: 20596921 DOI: 10.1007/s11427-010-0082-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
140 Boysen T, Friborg J, Stribolt K, Hamilton-Dutoit S, Goertz S, Wohlfahrt J, Melbye M. Epstein-Barr virus-associated gastric carcinoma among patients with pernicious anemia. Int J Cancer 2011;129:2756-60. [PMID: 21225628 DOI: 10.1002/ijc.25925] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
141 Camargo MC, Koriyama C, Matsuo K, Kim WH, Herrera-Goepfert R, Liao LM, Yu J, Carrasquilla G, Sung JJ, Alvarado-Cabrero I. Case-case comparison of smoking and alcohol risk associations with Epstein-Barr virus-positive gastric cancer. Int J Cancer. 2014;134:948-953. [PMID: 23904115 DOI: 10.1002/ijc.28402] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
142 Fukayama M. Epstein-Barr virus and gastric carcinoma. Pathol Int. 2010;60:337-350. [PMID: 20518883 DOI: 10.1111/j.1440-1827.2010.02533.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 79] [Article Influence: 7.3] [Reference Citation Analysis]
143 Liu X, Liu J, Qiu H, Kong P, Chen S, Li W, Zhan Y, Li Y, Chen Y, Zhou Z, Xu D, Sun X. Prognostic significance of Epstein-Barr virus infection in gastric cancer: a meta-analysis. BMC Cancer 2015;15:782. [PMID: 26498209 DOI: 10.1186/s12885-015-1813-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
144 Rihane FE, Erguibi D, Elyamine O, Abumsimir B, Ennaji MM, Chehab F. Helicobacter pylori co-infection with Epstein-Barr virus and the risk of developing gastric adenocarcinoma at an early age: Observational study infectious agents and cancer. Ann Med Surg (Lond) 2021;68:102651. [PMID: 34386233 DOI: 10.1016/j.amsu.2021.102651] [Reference Citation Analysis]
145 Huh CW, Jung DH, Kim H, Kim H, Youn YH, Park H, Kim JW, Choi SH, Noh SH, Kim JH. Clinicopathologic features of gastric carcinoma with lymphoid stroma in early gastric cancer. J Surg Oncol. 2016;114:769-772. [PMID: 27450278 DOI: 10.1002/jso.24385] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
146 Liu S, Jin L, Xu X, Lin N, Lei B, Shen H. Pathological and computed tomography findings of lymphoepithelioma-like gastric carcinoma with epithelioid granulomas: A case report. Oncol Lett 2013;5:549-51. [PMID: 23420641 DOI: 10.3892/ol.2012.1070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
147 Shin DH, Kim GH, Lee BE, Lee JW, Ha DW, Jeon HK, Baek DH, Song GA, Ahn SJ, Park DY. Clinicopathologic features of early gastric carcinoma with lymphoid stroma and feasibility of endoscopic submucosal dissection. Surg Endosc. 2017;31:4156-4164. [PMID: 28409376 DOI: 10.1007/s00464-017-5470-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
148 Nogueira C, Mota M, Gradiz R, Cipriano MA, Caramelo F, Cruz H, Alarcão A, E Sousa FC, Oliveira F, Martinho F, Pereira JM, Figueiredo P, Leitão M. Prevalence and characteristics of Epstein-Barr virus-associated gastric carcinomas in Portugal. Infect Agent Cancer 2017;12:41. [PMID: 28814970 DOI: 10.1186/s13027-017-0151-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
149 He D, Zhang Y, Zhang N, Zhou L, Chen J, Jiang Y, Shao C. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein–Barr virus-associated gastric carcinomas. Med Oncol 2015;32. [DOI: 10.1007/s12032-015-0525-y] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
150 Olivares-Hernández A, Figuero-Pérez L, Miramontes-González JP, López-Gutiérrez Á, González-Sarmiento R, Cruz-Hernández JJ, Fonseca-Sánchez E. Immune System Disorders, Cancer and Viral Infections: A New Treatment Opportunity for the Immune Checkpoint Inhibitors. Life (Basel) 2021;11:1400. [PMID: 34947931 DOI: 10.3390/life11121400] [Reference Citation Analysis]
151 Baek DW, Kang BW, Hwang S, Kim JG, Seo AN, Bae HI, Kwon OK, Lee SS, Chung HY, Yu W. Clinical Significance of p53 Protein Expression, Beta-catenin Expression and HER2 Expression for Epstein-Barr Virus-associated Gastric Cancer. Chonnam Med J 2017;53:140-6. [PMID: 28584793 DOI: 10.4068/cmj.2017.53.2.140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
152 BenAyed-Guerfali D, Ayadi W, Miladi-Abdennadher I, Khabir A, Sellami-Boudawara T, Gargouri A, Mokdad-Gargouri R. Characteristics of epstein barr virus variants associated with gastric carcinoma in Southern Tunisia. Virol J. 2011;8:500. [PMID: 22047541 DOI: 10.1186/1743-422x-8-500] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]